A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight
Status:
Recruiting
Trial end date:
2025-05-16
Target enrollment:
Participant gender:
Summary
The main purpose of this study, performed under a master protocol W8M-MC-CWMM (NCT06143956),
is to investigate weight management efficacy and safety with LY3305677 compared with placebo
and in adult participants with obesity or overweight. The study will last about 62 weeks.